Assessment of pharmaceutical pollutants in surface water of Ukraine

Authors

  • L. V. Ievsieieva Public organization "Social and Environmental Security", Ukraine
  • K. Yu. Netyosova National University of Pharmacy, Ukraine
  • Yu. I. Gubin National University of Pharmacy, Ukraine
  • I. O. Zhuravel Kharkiv Medical Academy of Postgraduate Education, Ukraine
  • N. G. Bondar National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/uekj.16.40

Keywords:

pharmaceutical pollutants in the environment, risk assessment, the predicted environmental concentration, surface waters of Ukraine

Abstract

Global presence of low levels of medicines in wastewater, surface water and groundwater is confirmed by recent investigations. Issues about the possible risks and consequences of pharmaceutical pollutants for the environment and human require an evaluation of the presence of medical substances in surface waters in Ukraine and, if necessary, their inclusion in area of chemical security. Based on the analysis of medicines consumption their predicted  environmental concentration (PEC) was calculated; priority pollutants of surface waters in Ukraine was determined among the antibiotics, hypoglycemic agents and analgesics.

References

Кириченко О. М. Фармакотерапія цукрового діабету II типу: оцінка споживання пероральних цукрознижувальних препаратів на українському фармацевтичному ринку / О. М. Кириченко, О. А. Кириченко, О. І. Леонченко // Clinical Pharmacy. – 2015. – Vol. 19, № 2. – С. 14-18.

Матяшова Н. О. Аналіз споживання макролідів в Україні / Н. О. Матяшова, Л. В. Яковлєва // Клінічна фармація. – 2015. – T. 19, № 2. – С. 19-22.

Мостовой Ю. И. Применение антибиотиков в Украине: закономерности и тенденции / Ю. И. Мостовой, А. В. Демчук // Антибиотикотерапия. – 2012. – № 21 (298). Режим доступу: www.health-ua.com

Потребление гипогликемизирующих препаратов в Украине. Анализ рынка аптечных продаж за первые 5 мес. 2008 г. // Еженедельник Аптека 648 (27) 07.07.2008. Режим доступу: http://www.apteka.ua/article/6810

Токсичность для водных объектов. Оценка технологий с точки зрения токсичности для водных объектов. Режим доступу: http://alternativatech.com/printsipy-kompleksnoj-otsenki-vozdejstviyana-okruzhayushchuyu-sredu/14-toksichnost- dlya-vodnykh-ob-ektov.html

Яковлєва Л. В. Аналіз амбулаторного споживання пеніцилінових антибіотиків в Україні / Л. В. Яковлєва, Н. О. Матяшова // Фармац. журн. – 2013. – № 1. – С. 26-31.

Яковлева Л. В., Алексейчук А. А. Исследование потребления антибиотиков группы фторхинолонов, представленных на украинском рынке, по ATC/DDD методологии // Матер. II науч.-практ. конф. «Фармакоэкономика в Украине: состояние и перспективы развития», Харьков, 21-22 мая 2009. – Х., 2009. – 364 с.

Achilleos M., Vasquez Hadjilyra I., Hapeshi E. et al. // Predicted environmental concentrations of selected pharmaceutical active ingredients in urban wastewaters in Cyprus: International Conference on the Protection and Restoration of the Environment IX, Kefalonia, Greece, 29 June – 3 July 2008.

Besse J. P. Exposure Assessment of Pharmaceuticals and Their Metabolites in the Aquatic Environment: Application to the French Situation and Preliminary Prioritization / J. P. Besse, C. Kausch Barreto, J. Garric // J. of Human and Ecol. Risk Assessment. – 2008. – 14 (4). – P. 665-695.

Cunningham V. L. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment / V. L. Cunningham, S. P. Binks, M. J. Olson // Regul. Toxicol. Pharmacol. – 2009. – Vol. 53. – P. 39-45.

Daughton C. G. Pharmaceuticals and personal care products in the environment: Agents of subtle change? / C. G. Daughton, T. A. Ternes // Environ. Health Perspect. – 1999. – Vol. 107. – P. 907-938.

Daughton C. G. Pharmaceutical Ingredients in Drinking Water: Overview of Occurrence and Significance of Human Exposure. ACS Symposium Series, Vol. 1048; American Chemical Society: Washington, DC, USA. – 2010. – P. 9-68.

DDD Definition and general considerations. Available online: https://en.wikipedia.org/wiki/Defined_daily_dose

Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00

Human Antimicrobial Drug Use Report 2012/2013/ Public Health Agency of Canada. Available online: http://www.phac-aspc.gc.ca/publicat/hamdur-rumamh/2012-2013/02-eng.php

Murdoch R. Pharmaceutical Pollution in the Environment: Issues for Australia, New Zealand and Pacific Island countries. May 2015. Available online: www.ntn.org.au

Owens B. Pharmaceuticals in the environment: a growing problem / B. Owens // Pharm. J. – 2015. – Vol. 294, No 7850.

Pharmaceuticals in drinking-water/ WHO/HSE/WSH/11.05/ World Health Organization 2011.

Randhir P. Deo Pharmaceuticals in the Built and Natural Water Environment of the United States / P. Deo Randhir, U. Halden Rolf // Water. – 2013. – Vol. 5 (3). – P. 1346-1365.

STOWA 2013-23 KWR 2013-062 Human pharmaceuticals in the water cycle. Available online: http://www.stowa.nl/upload/publicaties/STOWA%202013%2023.pdf

Study on the environmental risks of medicinal products. FINAL REPORT. BIO Intelligence Service. – 2013. – Р. 310.

USEPA. Summary of the Clean Water Act. Available online: https://www.epa.gov/lawsregulations/summary-clean-water-act

WHO Collaborating Centre for Drug Statistics Methodology (WHOCC). Available online: http://www.whocc.no/atc_ddd_index

Zusammenstellung von Monitoringdaten zu Umweltkonzentrationen von Arzneimitteln. – Dessau-Roßlau, Oktober 2011.

Downloads

Published

2016-11-23

Issue

No. 4(48) (2016)

Section

Quality, standardization and certification in pharmacy

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Авторський договір